These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 34885253)

  • 1. miRNAs in the Regulation of Cancer Immune Response: Effect of miRNAs on Cancer Immunotherapy.
    Pottoo FH; Iqubal A; Iqubal MK; Salahuddin M; Rahman JU; AlHajri N; Shehadeh M
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications.
    Mondal P; Kaur B; Natesh J; Meeran SM
    Semin Cell Dev Biol; 2022 Apr; 124():99-113. PubMed ID: 33865701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of miRNAs in immune responses and immunotherapy in cancer.
    Cortez MA; Anfossi S; Ramapriyan R; Menon H; Atalar SC; Aliru M; Welsh J; Calin GA
    Genes Chromosomes Cancer; 2019 Apr; 58(4):244-253. PubMed ID: 30578699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy.
    Veiga RN; Zambalde ÉP; Cox L; Jucoski TS; Kohler AF; Carvalho TM; Rodrigues AC; Ludwig B; Crowley K; de Oliveira JC; Cortez MA
    Adv Exp Med Biol; 2022; 1385():75-108. PubMed ID: 36352211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cancer-derived microRNAs in cancer immune escape.
    Yi M; Xu L; Jiao Y; Luo S; Li A; Wu K
    J Hematol Oncol; 2020 Mar; 13(1):25. PubMed ID: 32222150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs as Key Players in the Management of Cutaneous Melanoma.
    Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNAs as novel immunotherapeutic tools against cancer.
    Kaur M; Kaur B; Konar M; Sharma S
    Adv Protein Chem Struct Biol; 2022; 129():135-161. PubMed ID: 35305717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules.
    Alotaibi F
    Front Genet; 2023; 14():1052731. PubMed ID: 36873941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway.
    Zhang J; Luo Q; Li X; Guo J; Zhu Q; Lu X; Wei L; Xiang Z; Peng M; Ou C; Zou Y
    Biomark Res; 2023 Oct; 11(1):86. PubMed ID: 37784183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma.
    Nguyen MT; Luo YH; Li AL; Tsai JC; Wu KL; Chung PJ; Ma N
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.
    Iqbal MA; Arora S; Prakasam G; Calin GA; Syed MA
    Mol Aspects Med; 2019 Dec; 70():3-20. PubMed ID: 30102929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting microRNAs as key modulators of tumor immune response.
    Paladini L; Fabris L; Bottai G; Raschioni C; Calin GA; Santarpia L
    J Exp Clin Cancer Res; 2016 Jun; 35():103. PubMed ID: 27349385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.
    Vishnubalaji R; Shaath H; Elango R; Alajez NM
    Semin Cancer Biol; 2020 Oct; 65():65-79. PubMed ID: 31733291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment.
    Omar HA; El-Serafi AT; Hersi F; Arafa EA; Zaher DM; Madkour M; Arab HH; Tolba MF
    FEBS J; 2019 Sep; 286(18):3540-3557. PubMed ID: 31306553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
    Di Martino MT; Riillo C; Scionti F; Grillone K; Polerà N; Caracciolo D; Arbitrio M; Tagliaferri P; Tassone P
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of microRNAs in breast cancer stem cells.
    Schwarzenbacher D; Balic M; Pichler M
    Int J Mol Sci; 2013 Jul; 14(7):14712-23. PubMed ID: 23860207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune escape mechanisms and immunotherapy of urothelial bladder cancer.
    Yang Z; Xu Y; Bi Y; Zhang N; Wang H; Xing T; Bai S; Shen Z; Naz F; Zhang Z; Yin L; Shi M; Wang L; Wang L; Wang S; Xu L; Su X; Wu S; Yu C
    J Clin Transl Res; 2021 Aug; 7(4):485-500. PubMed ID: 34541363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer.
    Kousar K; Ahmad T; Abduh MS; Kanwal B; Shah SS; Naseer F; Anjum S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.